247 related articles for article (PubMed ID: 20610645)
1. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma.
Choi BK; Kim YH; Kim CH; Kim MS; Kim KH; Oh HS; Lee MJ; Lee DK; Vinay DS; Kwon BS
J Immunol; 2010 Aug; 185(3):1404-11. PubMed ID: 20610645
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells.
Kim YH; Choi BK; Shin SM; Kim CH; Oh HS; Park SH; Lee DG; Lee MJ; Kim KH; Vinay DS; Kwon BS
J Immunol; 2011 Aug; 187(3):1120-8. PubMed ID: 21715692
[TBL] [Abstract][Full Text] [Related]
3. Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo.
Choi BK; Kim YH; Choi JH; Kim CH; Kim KS; Sung YC; Lee YM; Moffett JR; Kwon BS
Cytokine; 2011 Sep; 55(3):420-8. PubMed ID: 21700476
[TBL] [Abstract][Full Text] [Related]
4. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
Kosaka A; Wakita D; Matsubara N; Togashi Y; Nishimura S; Kitamura H; Nishimura T
Int Immunol; 2007 Mar; 19(3):249-56. PubMed ID: 17229818
[TBL] [Abstract][Full Text] [Related]
5. IL-15 has innate anti-tumor activity independent of NK and CD8 T cells.
Davies E; Reid S; Medina MF; Lichty B; Ashkar AA
J Leukoc Biol; 2010 Sep; 88(3):529-36. PubMed ID: 20538758
[TBL] [Abstract][Full Text] [Related]
6. The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses.
Crespo FA; Sun X; Cripps JG; Fernandez-Botran R
J Leukoc Biol; 2006 Mar; 79(3):586-95. PubMed ID: 16415169
[TBL] [Abstract][Full Text] [Related]
7. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy.
Choi BK; Kim YH; Kang WJ; Lee SK; Kim KH; Shin SM; Yokoyama WM; Kim TY; Kwon BS
Cancer Res; 2007 Sep; 67(18):8891-9. PubMed ID: 17875731
[TBL] [Abstract][Full Text] [Related]
9. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
Bohn E; Autenrieth IB
J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells and Stat3 are essential for CD137-induced CD8 T cell activation-induced cell death.
Zhang B; Zhang Y; Niu L; Vella AT; Mittler RS
J Immunol; 2010 May; 184(9):4770-8. PubMed ID: 20351189
[TBL] [Abstract][Full Text] [Related]
11. Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody.
Ju SA; Park SM; Lee SC; Kwon BS; Kim BS
Mol Cells; 2007 Aug; 24(1):132-8. PubMed ID: 17846508
[TBL] [Abstract][Full Text] [Related]
12. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma.
Hoshino T; Winkler-Pickett RT; Mason AT; Ortaldo JR; Young HA
J Immunol; 1999 Jan; 162(1):51-9. PubMed ID: 9886369
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation.
Shin SM; Kim YH; Choi BK; Kwon PM; Lee HW; Kwon BS
J Leukoc Biol; 2007 Jun; 81(6):1455-65. PubMed ID: 17389581
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
Vinay DS; Kwon BS
Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice.
Comes A; Di Carlo E; Musiani P; Rosso O; Meazza R; Chiodoni C; Colombo MP; Ferrini S
Eur J Immunol; 2002 Jul; 32(7):1914-23. PubMed ID: 12115611
[TBL] [Abstract][Full Text] [Related]
17. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver.
Miyagi T; Takehara T; Tatsumi T; Suzuki T; Jinushi M; Kanazawa Y; Hiramatsu N; Kanto T; Tsuji S; Hori M; Hayashi N
Hepatology; 2004 Nov; 40(5):1190-6. PubMed ID: 15486936
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells.
Vosskuhl K; Greten TF; Manns MP; Korangy F; Wedemeyer J
J Immunol; 2010 Jul; 185(1):119-25. PubMed ID: 20511546
[TBL] [Abstract][Full Text] [Related]
20. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]